Evidence map›Paper›PMID 37457627›Full record

ArticleJournal of biomedical optics2023

Mapping estimates of vascular permeability with a clinical indocyanine green fluorescence imaging system in experimental pancreatic adenocarcinoma tumors.

Matthew S Reed, Marien Ochoa, Kenneth M Tichauer, Ashley Weichmann, Marvin M Doyley, Brian W Pogue

Open access · goldAbstract read
In one paragraph

Article in Journal of biomedical optics, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 8 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Matthew S ReedUniversity of Wisconsin-Madison, Department of Medical Physics, Madison, Wisconsin, United States.ORCID 0009-0002-2134-5844
Marien OchoaUniversity of Wisconsin-Madison, Department of Medical Physics, Madison, Wisconsin, United States.ORCID 0000-0001-6427-4447
Kenneth M TichauerIllinois Institute of Technology, Department of Biomedical Engineering, Chicago, Illinois, United States.ORCID 0000-0003-1667-3026
Ashley WeichmannUniversity of Wisconsin-Madison, Department of Medical Physics, Madison, Wisconsin, United States.
Marvin M DoyleyUniversity of Rochester, Department of Electrical and Computer Engineering, Rochester, New York, United States.
Brian W PogueUniversity of Wisconsin-Madison, Department of Medical Physics, Madison, Wisconsin, United States.ORCID 0000-0002-9887-670X
University of Wisconsin–Madison · USIllinois Institute of Technology · USUniversity of Rochester · US

Funding

UW COMPREHENSIVE CANCER CENTER SUPPORTP30CA014520 · NCI · UNIVERSITY OF WISCONSIN-MADISON · PI Justine Yang Bruce · 1985 to 2026
$142.6M
Small Molecule Enhancers of Photodynamic Therapy for Skin CancerP01CA084203 · NCI · MASSACHUSETTS GENERAL HOSPITAL · PI Brian William Pogue · 2001 to 2026
$27.9M
Surrogate biomarkers for assessing changes in pancreatic cancer tumor microenvironmentR01EB032337 · NIBIB · UNIVERSITY OF ROCHESTER · PI DOYLEY, MARVIN M · 2021 to 2024
$2.4M
NCI NIH HHS P01 CA084203NCI NIH HHS P30 CA014520NIBIB NIH HHS R01 EB032337
6 · The paper itself

Abstract

Significance: Pancreatic cancer tumors are known to be avascular, but their neovascular capillaries are still chaotic leaky vessels. Capillary permeability could have significant value for therapy assessment, and its quantification might be possible with macroscopic imaging of indocyanine green (ICG) kinetics in tissue. Aim: The capacity of using standard fluorescence surgical systems for ICG kinetic imaging as a probe for capillary leakage was evaluated using a clinical surgical fluorescence imaging system, as interpreted through vascular permeability modeling. Approach: Xenograft pancreatic adenocarcinoma models were imaged in mice during bolus injection of ICG to capture the kinetics of uptake. Image analysis included ratiometric data, normalization, and match to theoretical modeling. Kinetic data were converted into the extraction fraction of the capillary leakage. Results: Pancreatic tumors were usually less fluorescent than the surrounding healthy tissues, but still the rate of tumor perfusion could be assessed to quantify capillary extraction. Model simulations showed that flow kinetics stabilized after about 1 min beyond the initial bolus injection and that the relative extraction fraction model estimates matched the experimental data of normalized uptake within the tissue. The kinetics in the time period of 1 to 2 min post-injection provided optimal differential data between AsPC1 and BxPC3 tumors, although high individual variation exists between tumors. Conclusions: ICG kinetic imaging during the initial leakage phase was diagnostic for quantitative vascular permeability within pancreatic tumors. Methods for autogain correction and normalized model-based interpretation allowed for quantification of extraction fraction and difference identification between tumor types in early timepoints.

Indexed as

AdenocarcinomaNeoplasms, ExperimentalPancreatic NeoplasmsAnimalsCapillary PermeabilityDisease Models, AnimalHumansIndocyanine GreenMiceOptical ImagingIndocyanine Greenangiogenesisfluorescenceimaging systemsindocyanine greensurgerytumor

Identifiers

PMID37457627
PMCPMC10344470
OpenAlexW4384155381

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.